Clean Yield Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Clean Yield Group’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$164K	Buy	330 +8	+2%	+$3.54K	0.04%	161
2026 Q1	$144K	Hold	322	–	–	0.04%	160
2025 Q4	$146K	Hold	322	–	–	0.04%	156
2025 Q3	$126K	Hold	322	–	–	0.04%	154
2025 Q2	$143K	Sell	322 -4	-1%	-$1.84K	0.04%	149
2025 Q1	$158K	Buy	326 +11	+3%	+$5.13K	0.05%	143
2024 Q4	$127K	Sell	315 -3	-0.9%	-$1.39K	0.04%	158
2024 Q3	$148K	Buy	318 +10	+3%	+$4.8K	0.05%	151
2024 Q2	$144K	Buy	308 +8	+3%	+$3.47K	0.05%	139
2024 Q1	$125K	Hold	300	–	–	0.05%	157
2023 Q4	$122K	Hold	300	–	–	0.05%	160
2023 Q3	$110K	Hold	300	–	–	0.05%	163
2023 Q2	$106K	Hold	300	–	–	0.04%	172
2023 Q1	$94.5K	Hold	300	–	–	0.04%	179
2022 Q4	$86.6K	Sell	300 -11	-4%	-$3.35K	0.04%	188
2022 Q3	$90K	Buy	311 +11	+4%	+$3.17K	0.04%	184
2022 Q2	$85K	Hold	300	–	–	0.04%	197
2022 Q1	$78K	Hold	300	–	–	0.03%	219
2021 Q4	$66K	Hold	300	–	–	0.02%	245
2021 Q3	$54K	Hold	300	–	–	0.02%	258
2021 Q2	$60K	Buy	+300	New	+$62.8K	0.02%	241
2021 Q1	–	Sell	-300	Closed	-$71K	–	372
2020 Q4	$71K	Hold	300	–	–	0.03%	219
2020 Q3	$82K	Hold	300	–	–	0.03%	189
2020 Q2	$87K	Hold	300	–	–	0.04%	174
2020 Q1	$71K	Hold	300	–	–	0.03%	172
2019 Q4	$66K	Hold	300	–	–	0.02%	207
2019 Q3	$51K	Hold	300	–	–	0.02%	211
2019 Q2	$55K	Buy	+300	New	+$52.4K	0.02%	199

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Clean Yield Group's VRTX Position: Q2 2026 in Review

Clean Yield Group increased its Vertex Pharmaceuticals (VRTX) stake by 2.5% in Q2 2026, buying an estimated $3.54K and bringing the position to 330 shares worth $164K. The position accounts for 0.04% of the portfolio, ranked #161.

Clean Yield Group first reported a position in VRTX in Q2 2019 and has held it in 28 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Clean Yield Group held 330 shares of Vertex Pharmaceuticals worth $164K as of Q2 2026.
Clean Yield Group bought 8 Vertex Pharmaceuticals shares in Q2 2026, an estimated $3.54K.
Vertex Pharmaceuticals made up 0.04% of Clean Yield Group's portfolio in Q2 2026, its #161 holding.
Clean Yield Group first reported a position in Vertex Pharmaceuticals in Q2 2019 and has held it in 28 quarters since.
1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Clean Yield Group's 13F filing for Q2 2026, filed 5 Aug 2026.